1. Home
  2. VOYA vs GRFS Comparison

VOYA vs GRFS Comparison

Compare VOYA & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VOYA
  • GRFS
  • Stock Information
  • Founded
  • VOYA 1975
  • GRFS 1940
  • Country
  • VOYA United States
  • GRFS Spain
  • Employees
  • VOYA N/A
  • GRFS N/A
  • Industry
  • VOYA Life Insurance
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • VOYA Finance
  • GRFS Health Care
  • Exchange
  • VOYA Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • VOYA 7.4B
  • GRFS 6.6B
  • IPO Year
  • VOYA 2013
  • GRFS 2006
  • Fundamental
  • Price
  • VOYA $75.08
  • GRFS $9.95
  • Analyst Decision
  • VOYA Buy
  • GRFS Hold
  • Analyst Count
  • VOYA 12
  • GRFS 1
  • Target Price
  • VOYA $83.17
  • GRFS $10.30
  • AVG Volume (30 Days)
  • VOYA 710.9K
  • GRFS 553.6K
  • Earning Date
  • VOYA 11-04-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • VOYA 2.40%
  • GRFS 1.43%
  • EPS Growth
  • VOYA N/A
  • GRFS 132.60
  • EPS
  • VOYA 5.01
  • GRFS 0.53
  • Revenue
  • VOYA $7,916,000,000.00
  • GRFS $8,744,226,659.00
  • Revenue This Year
  • VOYA N/A
  • GRFS $5.61
  • Revenue Next Year
  • VOYA $3.59
  • GRFS $6.70
  • P/E Ratio
  • VOYA $15.00
  • GRFS $25.25
  • Revenue Growth
  • VOYA 2.46
  • GRFS 9.32
  • 52 Week Low
  • VOYA $52.43
  • GRFS $6.19
  • 52 Week High
  • VOYA $84.30
  • GRFS $11.14
  • Technical
  • Relative Strength Index (RSI)
  • VOYA 48.90
  • GRFS 51.32
  • Support Level
  • VOYA $73.61
  • GRFS $9.88
  • Resistance Level
  • VOYA $76.65
  • GRFS $10.23
  • Average True Range (ATR)
  • VOYA 1.40
  • GRFS 0.18
  • MACD
  • VOYA -0.30
  • GRFS 0.03
  • Stochastic Oscillator
  • VOYA 36.12
  • GRFS 54.10

About VOYA Voya Financial Inc.

Voya Financial Inc is a financial services company, which, through its subsidiaries, provides various investment, insurance, and retirement solutions to individual and institutional clients in the United States. Its products and services include tax savings plans, individual retirement accounts, group life insurance plans, and employee benefits products, among others. The company tailors each of its products to the needs of its customer base. It operates its business through three principal lines: Wealth Solutions, Investment Management, and Health Solutions The Wealth segment generates roughly half of the company's revenue.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: